Conservation efforts began years ago to stop the lichen, a combination of a fungus and algae, from damaging the site's ...
Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...
Lipella Pharma completes dosing for first cohort in phase 2a trial of LP-310 for oral lichen planus: Pittsburgh Saturday, November 23, 2024, 18:00 Hrs [IST] Lipella Pharmaceutical ...